Oyster Point Pharma Inc.


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Oyster Point Pharma Inc is a biopharmaceutical company focused on the development of pharmaceutical therapies to treat ocular surface diseases. Its product candidate OC-01 is a nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.

Contact Information

Website: www.oysterpointrx.com
Main Phone: +1 609 382-9032
Address: 202 Carnegie Center
Address 2: Suite 109
State: NJ
City / Town: Princeton
Country: US
Postal Code: 08540

Issuer Information

Exchange: NGS
CEO: Jeffrey Nau
Employees: 62
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A